BOULDER, Colo.--(BUSINESS WIRE)--Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Leerink Swann Conquering Cancer with Novel Therapeutics: Roundtable Conference on May 9 in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
